OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy (Q2866833): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Removed claim: co-financing rate (P837): 76.0 percent, Removing co-finance rate from projects in portugal) |
||||||
| Property / co-financing rate | |||||||
| |||||||
| Property / co-financing rate: 76.0 percent / rank | |||||||
Revision as of 10:04, 13 September 2021
Project Q2866833 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | OncoAlvo.: Technological Innovation Optimised for the Personalisation of Oncology Therapy |
Project Q2866833 in Portugal |
Statements
349,140.37 Euro
0 references
1 March 2016
0 references
1 March 2018
0 references
HEARTGENETICS GENETICS AND BIOTECHNOLOGY, S.A.
0 references
40°21'55.76"N, 8°39'29.95"W
0 references
Cantanhede
0 references
Identifiers
CENTRO-01-0247-FEDER-010500
0 references